| 000 | 01149 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517063136.0 | ||
| 264 | 0 | _c20161014 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1756-591X | ||
| 024 | 7 |
_a10.1039/c5mt00181a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParker, James P | |
| 245 | 0 | 0 |
_aExploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer. _h[electronic resource] |
| 260 |
_bMetallomics : integrated biometal science _cJan 2016 |
||
| 300 |
_a43-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNanotechnology _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPlatinum _xchemistry |
| 700 | 1 | _aUde, Ziga | |
| 700 | 1 | _aMarmion, Celine J | |
| 773 | 0 |
_tMetallomics : integrated biometal science _gvol. 8 _gno. 1 _gp. 43-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1039/c5mt00181a _zAvailable from publisher's website |
| 999 |
_c25448485 _d25448485 |
||